Pharma News

Many neurodegenerative diseases, including Alzheimer’s and Parkinson’s, are difficult to diagnose before symptoms begin to appear. However, disease-related biomarkers such as aggregated proteins called amyloids could provide important insight much earlier, if they can be readily detected. Researchers publishing in ACS Sensors have developed one such method using an array of sensor molecules that can light up amyloids. The tool could help monitor disease progression or distinguish between different amyloid-related conditions.

Disrupted function of “cleaning cells” in the body may help to explain why some people with obesity develop type 2 diabetes, while others do not. A study from the University of Gothenburg describes this newly discovered mechanism.

The 7th Annual Pharma Project and Portfolio Management 2024, held at Fairfield By Marriott in South Goa from January 17th to 19th, 2024, marked a significant milestone as of the best EBM event to date. Addressing challenging R&D project issues, the conference offered a comprehensive program to tackle industry pain points and enhance understanding of intellectual property (IP) and portfolio dynamics within the global pharma sector.

Aiming for Viksit Bharat by 2047 and with a sharp focus and providing momentum to Nari Shakti, Union Minister for Finance & Corporate Affairs, Smt. Nirmala Sitharaman today proposed vaccination to prevent Cervical Cancer and amalgamation of various schemes for maternal and child care, as she presented the Interim Budget 2024-25 in Parliament today.

IIHMR University, Jaipur is organizing a 5-day Training Program on “Public Health Management for District and Block Level Officials, Odisha” from February 2–6, 2024. Twenty-eight District and Block Public Health Communication Officers from Government of Odisha are set to benefit from a robust learning ecosystem that seamlessly blends theoretical foundations with practical applications.

IIHMR Startups, a unit of IIHMR Foundation, proudly announces the success of Jigyasa Episode 6, a captivating fireside chat featuring Dr. Sameer Agarwal, CEO, and Mr. Puneet Sethi, COO of Bio Hubb. The event, held on January 23 rd , 2024, showcased insightful discussions on the future of biobanking and the innovative strides Bio Hubb is making in advancing scientific research.

In a groundbreaking study, a team led by Würzburg Professor José Pedro Friedmann Angeli has shown that the cholesterol precursor 7-dehydrocholesterol (7-DHC) plays a crucial role as an antioxidant: it integrates into the cell membranes and protects the cells by preventing a certain type of cell death, known as ferroptosis.

Zydus Lifesciences Ltd., a global innovation driven healthcare company announced that it has launched Relugolix under the brand name, Rexigo™. This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India. Though Relugolix was available in developed countries since the last four years, patients in India did not have access to it. With this launch, Zydus brings both access to a critical therapy and also makes it affordable at a cost of Rs.

Pfizer and Glenmark Pharmaceuticals Ltd have joined hands to launch abrocitinib, a first of its kind oral advanced systemic treatment for moderate‐to‐severe atopic dermatitis (AD), in India. Developed by Pfizer, abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India and is approved by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies.